RecruitingNCT05965453

Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome

Real-world Experience With the Castor Single Branch Stent Graft in the Management of Acute Aortic Syndrome


Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Enrollment

205 participants

Start Date

Jun 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this study to evaluate the safety and effectiveness of the Castor single branch stent graft for endovascular repair of acute aortic syndrome patients without an inadequate proximal landing zone (\<15mm)


Eligibility

Min Age: 18 YearsMax Age: 95 Years

Inclusion Criteria1

  • Patients with acute Stanford type B aortic syndrome who received thoracic endovascular aortic repair by meant of Castor single branch stent graft from June 2018 to June 2022

Exclusion Criteria3

  • Patients with acute type B aortic syndrome with an adequate proximal landing zone (≥15mm)
  • Previous endovascular repair of the aorta
  • Patients with missing data and loss of follow-up

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEthe Castor single branch stent graft

Participants who received thoracic endovascular aortic repair by meant of the Castor single branch stent graft from June 2018 to June 2022 were enrolled in our study.


Locations(1)

First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05965453


Related Trials